Not only does Crohns disease affect the entire gastrointestinal (GI) tract, but its sometimes linked to a liver complication called primary sclerosing cholangitis (PSC).PSC is rare, affecting up to 32 ...

Primary sclerosing cholangitis is an idiopathic, heterogeneous, cholestatic liver disease that is characterized by persistent, progressive, biliary inflammation and fibrosis. There is no effective ...

SAN DIEGO — Quantitative magnetic resonance cholangiopancreatography may help assess changes in the biliary tree and aid monitoring of patients with primary sclerosing cholangitis, according to ...

Primary sclerosing cholangitis (PSC) is a progressive scarring of the liver's bile ducts. According to current estimates, between 5 and 16 in every 100,000 people have PSC. The symptoms of PSC depend ...

PARIS — Statins can significantly reduce the risk for complications and death from primary sclerosing cholangitis, results from a Swedish registry study show. Primary sclerosing cholangitis is ...

Please provide your email address to receive an email when new articles are posted on . The ongoing phase 2 study is assessing bexotegrast in patients with primary sclerosing cholangitis and suspected ...

Primary biliary cholangitis (PBC), formerly known as primary biliary cirrhosis, and primary sclerosing cholangitis (PSC) both involve the breakdown of your bile ducts. Both conditions are also thought ...

—A recent study provides genetic evidence linking a higher body mass index (BMI) to an increased risk of primary biliary cholangitis and autoimmune hepatitis but a decreased risk of primary sclerosing ...

Primary sclerosing cholangitis is a chronic liver disease caused by progressive inflammation and scarring of the bile ducts of the liver. The inflammation impedes the flow of bile to the duodenum, ...

New Partnership Provides Unparalleled Insights for PSC Patients and Providers GREENWOOD VILLAGE, Colo.–(BUSINESS WIRE)–February 20, 2019– PSC Partners Seeking a Cure announced today a partnership with ...